NEXPOINT RESIDENTIAL (NXRT) Fundamental Analysis & Valuation

NYSE:NXRT • US65341D1028

26.87 USD
-0.53 (-1.93%)
At close: Mar 9, 2026
27.04 USD
+0.17 (+0.63%)
After Hours: 3/9/2026, 4:28:09 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This NXRT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

Taking everything into account, NXRT scores 2 out of 10 in our fundamental rating. NXRT was compared to 20 industry peers in the Residential REITs industry. NXRT may be in some trouble as it scores bad on both profitability and health. NXRT does not seem to be growing, but still is valued expensively. NXRT also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

3

1. NXRT Profitability Analysis

1.1 Basic Checks

  • NXRT had negative earnings in the past year.
  • In the past year NXRT had a positive cash flow from operations.
  • In multiple years NXRT reported negative net income over the last 5 years.
  • NXRT had a positive operating cash flow in each of the past 5 years.
NXRT Yearly Net Income VS EBIT VS OCF VS FCFNXRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200M -400M -600M

1.2 Ratios

  • With a Return On Assets value of -1.70%, NXRT is not doing good in the industry: 90.00% of the companies in the same industry are doing better.
  • NXRT has a Return On Equity of -10.84%. This is amonst the worse of the industry: NXRT underperforms 85.00% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 1.20%, NXRT is doing worse than 75.00% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for NXRT is in line with the industry average of 2.74%.
Industry RankSector Rank
ROA -1.7%
ROE -10.84%
ROIC 1.2%
ROA(3y)0.15%
ROA(5y)0.23%
ROE(3y)-0.54%
ROE(5y)0.3%
ROIC(3y)1.38%
ROIC(5y)1.2%
NXRT Yearly ROA, ROE, ROICNXRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • The Operating Margin of NXRT (11.22%) is worse than 70.00% of its industry peers.
  • NXRT's Operating Margin has improved in the last couple of years.
  • NXRT's Gross Margin of 62.91% is amongst the best of the industry. NXRT outperforms 85.00% of its industry peers.
  • NXRT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 11.22%
PM (TTM) N/A
GM 62.91%
OM growth 3Y-3.14%
OM growth 5Y9.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.61%
GM growth 5Y-7.59%
NXRT Yearly Profit, Operating, Gross MarginsNXRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. NXRT Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NXRT is destroying value.
  • NXRT has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for NXRT has been increased compared to 5 years ago.
  • NXRT has a worse debt/assets ratio than last year.
NXRT Yearly Shares OutstandingNXRT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
NXRT Yearly Total Debt VS Total AssetsNXRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • NXRT has an Altman-Z score of 0.36. This is a bad value and indicates that NXRT is not financially healthy and even has some risk of bankruptcy.
  • NXRT has a Altman-Z score of 0.36. This is in the lower half of the industry: NXRT underperforms 65.00% of its industry peers.
  • A Debt/Equity ratio of 5.27 is on the high side and indicates that NXRT has dependencies on debt financing.
  • NXRT has a Debt to Equity ratio of 5.27. This is amonst the worse of the industry: NXRT underperforms 90.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.27
Debt/FCF N/A
Altman-Z 0.36
ROIC/WACC0.18
WACC6.79%
NXRT Yearly LT Debt VS Equity VS FCFNXRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B

2.3 Liquidity

  • NXRT has a Current Ratio of 1.16. This is a normal value and indicates that NXRT is financially healthy and should not expect problems in meeting its short term obligations.
  • NXRT has a Current ratio of 1.16. This is in the better half of the industry: NXRT outperforms 75.00% of its industry peers.
  • NXRT has a Quick Ratio of 1.16. This is a normal value and indicates that NXRT is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.16, NXRT is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
NXRT Yearly Current Assets VS Current LiabilitesNXRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. NXRT Growth Analysis

3.1 Past

  • The earnings per share for NXRT have decreased strongly by -6450.00% in the last year.
  • NXRT shows a decrease in Revenue. In the last year, the revenue decreased by -3.24%.
  • Measured over the past years, NXRT shows a small growth in Revenue. The Revenue has been growing by 4.18% on average per year.
EPS 1Y (TTM)-6450%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.19%
Revenue 1Y (TTM)-3.24%
Revenue growth 3Y-1.63%
Revenue growth 5Y4.18%
Sales Q2Q%-2.67%

3.2 Future

  • Based on estimates for the next years, NXRT will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.04% on average per year.
  • The Revenue is expected to grow by 2.31% on average over the next years.
EPS Next Y-9.87%
EPS Next 2Y2.38%
EPS Next 3Y8.04%
EPS Next 5YN/A
Revenue Next Year2.3%
Revenue Next 2Y3.27%
Revenue Next 3Y3.81%
Revenue Next 5Y2.31%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NXRT Yearly Revenue VS EstimatesNXRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M 250M
NXRT Yearly EPS VS EstimatesNXRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

0

4. NXRT Valuation Analysis

4.1 Price/Earnings Ratio

  • NXRT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NXRT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NXRT Price Earnings VS Forward Price EarningsNXRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60 80

4.2 Price Multiples

  • NXRT's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 18.07
NXRT Per share dataNXRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.38%
EPS Next 3Y8.04%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. NXRT Dividend Analysis

5.1 Amount

  • NXRT has a Yearly Dividend Yield of 7.57%, which is a nice return.
  • NXRT's Dividend Yield is rather good when compared to the industry average which is at 44.33. NXRT pays more dividend than 85.00% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, NXRT pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.57%

5.2 History

  • On average, the dividend of NXRT grows each year by 10.38%, which is quite nice.
  • NXRT has been paying a dividend for at least 10 years, so it has a reliable track record.
  • NXRT has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)10.38%
Div Incr Years9
Div Non Decr Years9
NXRT Yearly Dividends per shareNXRT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • NXRT has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • NXRT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP-167.12%
EPS Next 2Y2.38%
EPS Next 3Y8.04%
NXRT Yearly Income VS Free CF VS DividendNXRT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200M -400M -600M

More info and screens

Find the best dividend stocksShow peers with best dividend

NXRT Fundamentals: All Metrics, Ratios and Statistics

NEXPOINT RESIDENTIAL

NYSE:NXRT (3/9/2026, 4:28:09 PM)

After market: 27.04 +0.17 (+0.63%)

26.87

-0.53 (-1.93%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)02-24
Earnings (Next)04-27
Inst Owners76.52%
Inst Owner Change-0.44%
Ins Owners13.4%
Ins Owner Change-1.14%
Market Cap682.77M
Revenue(TTM)251.28M
Net Income(TTM)-32.03M
Analysts73.85
Price Target33.46 (24.53%)
Short Float %3.16%
Short Ratio3.05
Dividend
Industry RankSector Rank
Dividend Yield 7.57%
Yearly Dividend2.11
Dividend Growth(5Y)10.38%
DP-167.12%
Div Incr Years9
Div Non Decr Years9
Ex-Date03-13
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.95%
Min EPS beat(2)-18.22%
Max EPS beat(2)12.33%
EPS beat(4)3
Avg EPS beat(4)5.32%
Min EPS beat(4)-18.22%
Max EPS beat(4)18.46%
EPS beat(8)5
Avg EPS beat(8)57.44%
EPS beat(12)7
Avg EPS beat(12)24.85%
EPS beat(16)8
Avg EPS beat(16)7%
Revenue beat(2)0
Avg Revenue beat(2)-2.54%
Min Revenue beat(2)-3.09%
Max Revenue beat(2)-2%
Revenue beat(4)0
Avg Revenue beat(4)-2.09%
Min Revenue beat(4)-3.09%
Max Revenue beat(4)-1.59%
Revenue beat(8)2
Avg Revenue beat(8)3.04%
Revenue beat(12)2
Avg Revenue beat(12)1.35%
Revenue beat(16)4
Avg Revenue beat(16)1.08%
PT rev (1m)0%
PT rev (3m)-3.53%
EPS NQ rev (1m)-4.42%
EPS NQ rev (3m)-4.58%
EPS NY rev (1m)-3.01%
EPS NY rev (3m)-5.23%
Revenue NQ rev (1m)-0.35%
Revenue NQ rev (3m)-0.41%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)-0.36%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.72
P/FCF N/A
P/OCF 8.17
P/B 2.31
P/tB 2.31
EV/EBITDA 18.07
EPS(TTM)-1.27
EYN/A
EPS(NY)-1.4
Fwd EYN/A
FCF(TTM)-1.27
FCFYN/A
OCF(TTM)3.29
OCFY12.24%
SpS9.89
BVpS11.63
TBVpS11.63
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.7%
ROE -10.84%
ROCE 1.51%
ROIC 1.2%
ROICexc 1.2%
ROICexgc 1.21%
OM 11.22%
PM (TTM) N/A
GM 62.91%
FCFM N/A
ROA(3y)0.15%
ROA(5y)0.23%
ROE(3y)-0.54%
ROE(5y)0.3%
ROIC(3y)1.38%
ROIC(5y)1.2%
ROICexc(3y)1.39%
ROICexc(5y)1.21%
ROICexgc(3y)1.42%
ROICexgc(5y)1.24%
ROCE(3y)1.74%
ROCE(5y)1.52%
ROICexgc growth 3Y-0.7%
ROICexgc growth 5Y12.9%
ROICexc growth 3Y0.67%
ROICexc growth 5Y12.74%
OM growth 3Y-3.14%
OM growth 5Y9.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.61%
GM growth 5Y-7.59%
F-Score3
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 5.27
Debt/FCF N/A
Debt/EBITDA 12.57
Cap/Depr 121.04%
Cap/Sales 46.12%
Interest Coverage 0.34
Cash Conversion 67.44%
Profit Quality N/A
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z 0.36
F-Score3
WACC6.79%
ROIC/WACC0.18
Cap/Depr(3y)78.06%
Cap/Depr(5y)165.13%
Cap/Sales(3y)28.73%
Cap/Sales(5y)63.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6450%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.19%
EPS Next Y-9.87%
EPS Next 2Y2.38%
EPS Next 3Y8.04%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.24%
Revenue growth 3Y-1.63%
Revenue growth 5Y4.18%
Sales Q2Q%-2.67%
Revenue Next Year2.3%
Revenue Next 2Y3.27%
Revenue Next 3Y3.81%
Revenue Next 5Y2.31%
EBIT growth 1Y-8.16%
EBIT growth 3Y-4.72%
EBIT growth 5Y13.61%
EBIT Next Year327.33%
EBIT Next 3Y65.59%
EBIT Next 5YN/A
FCF growth 1Y-188.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.61%
OCF growth 3Y1.86%
OCF growth 5Y7.87%

NEXPOINT RESIDENTIAL / NXRT FAQ

What is the ChartMill fundamental rating of NEXPOINT RESIDENTIAL (NXRT) stock?

ChartMill assigns a fundamental rating of 2 / 10 to NXRT.


Can you provide the valuation status for NEXPOINT RESIDENTIAL?

ChartMill assigns a valuation rating of 0 / 10 to NEXPOINT RESIDENTIAL (NXRT). This can be considered as Overvalued.


What is the profitability of NXRT stock?

NEXPOINT RESIDENTIAL (NXRT) has a profitability rating of 3 / 10.


What is the financial health of NEXPOINT RESIDENTIAL (NXRT) stock?

The financial health rating of NEXPOINT RESIDENTIAL (NXRT) is 2 / 10.


What is the expected EPS growth for NEXPOINT RESIDENTIAL (NXRT) stock?

The Earnings per Share (EPS) of NEXPOINT RESIDENTIAL (NXRT) is expected to decline by -9.87% in the next year.